Cargando…
Profound hyperacute cardiac allograft rejection rescue with biventricular mechanical circulatory support and plasmapheresis, intravenous immunoglobulin, and rituximab therapy
Hyperacute rejection is a rare but potentially catastrophic complication after cardiac transplantation. We describe an unusual case of hyperacute rejection due to preformed anti-donor antibodies despite a negative preoperative panel-reactive antibody (PRA) screen. An excellent outcome was achieved i...
Autores principales: | Kaczorowski, David J, Datta, Jashodeep, Kamoun, Malek, Dries, Daniel L, Woo, Y Joseph |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3626898/ https://www.ncbi.nlm.nih.gov/pubmed/23497431 http://dx.doi.org/10.1186/1749-8090-8-48 |
Ejemplares similares
-
Rituximab in Combination With Bortezomib, Plasmapheresis, and High-Dose IVIG to Treat Antibody-Mediated Renal Allograft Rejection
por: Waiser, Johannes, et al.
Publicado: (2016) -
Treatment with plasmapheresis, immunoglobulins and rituximab for chronic-active antibody-mediated rejection in kidney transplantation: Clinical, immunological and pathological results
por: Mella, Alberto, et al.
Publicado: (2018) -
Hyperacute Rejection of a Living Unrelated Kidney Graft
por: Tittelbach-Helmrich, Dietlind, et al.
Publicado: (2014) -
Recent strategies to overcome the hyperacute rejection in pig to human xenotransplantation.
por: Igaz, P.
Publicado: (2001) -
Preventive plasmapheresis for rituximab related flare in cryoglobulinemic vasculitis
por: Fornero, Léa, et al.
Publicado: (2023)